Cross John Harry III
Insider CIK 1806763 · SONN Chief Financial Officer · SNTI Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SNTI Senti Biosciences, Inc. | A Award deriv | 2025-03-07 | 2025-03-11 | 174,200 | — | $0 | 174,200 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | A Award | 2023-12-11 | 2024-12-05 | 1,452 | — | $0 | 1,588 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | F Tax w/h | 2023-02-06 | 2023-02-17 | 1,960 | $1.06 | $2.1K | 23,927 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | A Award | 2022-12-14 | 2022-12-22 | 15,519 | — | $0 | 160,684 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | A Award | 2021-12-15 | 2022-04-08 | 66,951 | — | $0 | 145,165 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | A Award | 2020-07-02 | 2020-07-02 | 78,214 | — | $0 | 78,214 | SEC↗ |